【24h】

TREATMENT PROTOCOLS FOR MANAGING TRANSURETHRAL THERMAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA

机译:经皮热疗对良性前列腺增生症的治疗方案

获取原文
获取原文并翻译 | 示例

摘要

Application of thermal therapy using microwave or ultrasound applicators is becoming increasingly popular as a minimally invasive treatment for benign prostatic hyperplasia (BPH). Successful management of the therapy using such methods requires an accurate estimation of the thermal dosage. The purpose of this study is to theoretically evaluate the thermal damage caused by different heating sources for different values of thermal doses and operating parameters. Using a 3-D finite differences method, the Pennes bio-heat transfer equation is solved for selected operating parameters. Necrosis zones are then determined from published necrosis data for prostatic tumor cells. Sample results are presented in terms of the temperature contours and necrosis zones. Results indicate that heating time and power level are the most important parameters in creating the desired necrosis zones, while coolant parameters strongly affect the temperatures of the sensitive urethra and serve as constraints for protocol parameters.
机译:作为用于良性前列腺增生(BPH)的微创治疗,使用微波或超声波施加器的热疗法的应用正变得越来越普遍。使用这样的方法成功地进行治疗需要准确估计热剂量。这项研究的目的是从理论上评估不同热源对不同剂量的热剂量和运行参数所造成的热损伤。使用3-D有限差分法,针对选定的运行参数求解了Pennes生物传热方程。然后从已公布的前列腺肿瘤细胞坏死数据中确定坏死区域。样品结果以温度等高线和坏死区表示。结果表明,加热时间和功率水平是创建所需坏死区的最重要参数,而冷却剂参数会强烈影响敏感尿道的温度,并成为协议参数的约束。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号